+ All Categories
Home > Documents > Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Date post: 12-Jan-2016
Category:
Upload: griffin-brent-waters
View: 271 times
Download: 5 times
Share this document with a friend
Popular Tags:
36
Antibiotics Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow
Transcript
Page 1: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Aminoglycoside Aminoglycoside AntibioticsAntibioticsProf. R. K. Dixit

Pharmacology and Therapeutics

K. G. M. U. Lucknow

Page 2: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

First member Streptomycin discovered by Waksman in 1944

Natural and semi-synthetic antibiotics

Produced from ActinomycetesThose obtained from Streptomyces – Have suffix mycinmycin (eg. Streptomycin)

Those obtained from Micromonospora – Have suffix

micinmicin (eg. Gentamicin,)

Page 3: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Structure characterized by Two aminosugars joined to One aminocyclitol moiety by Glycosidic (-O-) bond

In most of members aminoacyclitol moiety is 2-Deoxystreptamine .

In streptomycin the aminocyclitol is Streptidine.

Page 4: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

General character of General character of Aminoglycosides groupAminoglycosides groupFormulations are Sulfate or

hydrochloric saltsFormulations are water soluble and

stableHighly polar basic drugs. Ionize during dissolutionDistribution inside the cells is minimalPenetration through BBB is minimalLeast metabolized by hepatic enzymesExcretion is mainly renal (unchanged form,

through glomerular filtration)

(Not absorbed from GIT)(Not absorbed from GIT)

Page 5: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Bactericidal in natureMore active in alkaline pHMOA is by interfering with protein

synthesisAttach with 30S ribosomal subunit (ATT) Concentration dependent (PAE)Mainly gram negative (plus tuberculosis by

streptomycin, Kanamycin, Amikacin)Cross resistance is partialTherapeutic index is narrow

Page 6: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Have NONE side effects NephrotoxicOtotoxicNeuromuscular blockage

Etc.(Teratogenicity)

Page 7: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

NephrotoxicityNephrotoxicityStreptomycin is least nephrotoxic.Larger the number of NH2 more nephrotoxicity.Nephrotoxicity is caused by

Inhibition of an intracellular lysosomal phospholipase-A2 in renal brush border.

Leading to lysosomal distension, Rupture and Release of acid hydrolases Release of Free Aminoglycosides into cytosol. This free drug binds to other cellular organelles (eg. In

mitochondria it displaces Ca++ leading to mitochondrial degeneration and necrosis.)

Nephrotoxicity is reversibleVerapamil and Ca++ can

Reduce nephrotoxic potential ButAlso reduce antibacterial effect

Page 8: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

KAN (Kanamycin, Amikacin, Neomycin) mainly damage cochlea rest vestibular damage

All are teratogenic

Neomycin and Framycetin have extreme systemic toxicity ( only topically used)

Amikacin has widest spectrum

Avoid concurrent use of other Ototoxic drugs ( Frusemide, Ethacrinic acid, Minocycline)

Neomycin used orally for Hepatic Encephalopathy)Hepatic Encephalopathy)

Page 9: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Avoid concurrent use of other nephrotoxic drugs (Amphotericin B, Vancomycin, Cephalothin, Cephradrine, Cyclosporin, Cisplatin)

Be overcautious while using in extremes of age and renal compromised

Be overcautious while using in operated patients (Received Curare)

Page 10: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Don’t mix with any other drug (Pharmaceutical Drug Interaction)

Partially removed by peritoneal and haemodialysis

The excretion is proportional to creatinine clearance.

Half life increases in renal insufficiency.Dose adjustment is needed in renal insufficiencyMost precise method for calculating dose is using

creatinine clearanceBut in Practice most often used formula to

calculate dose is

Page 11: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

MembersMembersAmikacinStreptomycinSisomicinSpectinomycinKanamycinIspepamycinNetilmicinGentamicinTobramycin

ASKING Truth IS Great TASK

Page 12: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

MOAMOABactericidal (Gram Negative, No action on

Anaerobes)Initial entry of Aminoglycosides through

bacterial cell wall to periplasmic space Through porin channels by passive diffusion (1)

Later on further Entry across cytoplasmic membrane is carrier mediated (linked to (linked to electron transport chain, energy and oxygen electron transport chain, energy and oxygen dependent)dependent)Active transport (2)Active transport (2)

Advantage of adding Beta lactamsBeta Lactam antibiotics weaken the bacterial cell

wall Facilitate passive diffusion of Aminoglycoside.

(Synergism)

Page 13: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Penetration is dependent onMaintenance of polarized membraneOxygen dependent active process

Not active in absence of oxygenNot effective against anaerobesNot effective in presence of big abscess

pH alteration. Alkalization favors penetration into cell

Page 14: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Prevent polysome formation (accumulation of nonfunctional monosomes)

Inside the bacterial cell Aminoglycoside

bind with 30S ribosome subunit ( or at the interface of 30S and 50S)

Inhibit formation of initiation complexInhibit protein synthesisMisreading of mRNA CodonEntry of wrong amino acid in the chainFormation of wrong peptide chain

(Check the growth of bacteria, Bacteriostatic)

Page 15: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

How Cidal action is achievedAns- Defective proteins incorporated in cell

membrane.Due to secondary changes in the integrity

of bacterial cell membrane. (Increase permeability for ions, amino acids, proteins- Leading to leaking of these out side)

Bonus of incorporation of defective protein in cell membrane

More entry of antibiotic occurs in to the cell. Further increasing affectivityDeath Of

Bacteria

Page 16: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Resistance developmentResistance development (Conjugation and transfer of plasmid) (Conjugation and transfer of plasmid)

Development and synthesis of plasmid mediated bacterial transferase enzyme (Acetyltransferase, Phosphotransferase, Adenylyltransferase), which inactivates Aminoglycosides.

Impermeability of porins, Impaired active transport

Inactivating enzymes in the cell membrane – Phosphorylate / Adenylate / Acetylate and inactivate Aminoglycosides

Phosphorylated / Adenylated / Acetylated conjugates of Aminoglycoside can not bind at target ribosomal subunit and site.

Decreased affinity of ribosomal proteins for binding with Aminoglycosides

Page 17: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Side effects and ToxicitySide effects and ToxicityOtotoxic- Ototoxic-

◦ Concentrated in labyrinthine fluid◦ Released from there when plasma concentration decreases.

Less seen in routine dose. (High dose, long time high chance) Damage of sensory and hair cells Vestibular-

◦ Presents with Vertigo, Ataxia, Nystagmus◦ (Headache, Nausea, Vomiting, Dizziness) ◦ Recover slowly ( Least recovery in elderly)

Cochlear- ◦ Starts from base spreads to apex. ◦ High frequency affected first ◦ Recovery is very poor. ◦ Deafness may be permanent, more in elderly◦ Presents with tinnitus (reversible) followed by hearing loss

(irreversible)

Page 18: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Nephrotoxicity- More damage of cortical nephronsRelated to total exposureMore in ElderlyMore in pre-existing renal diseaseReversibleTubular damage (Loss of concentrating

mechanism)Reduction in GFR (Interference with the

prostaglandin production in kidney)Urine contains albumin and castsNitrogen retention in body

Nephrotoxicity- Reduced clearance of Aminoglycosides – High blood levels of Aminoglycosides – High chances of Ototoxicity

Page 19: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Neuromuscular BlockadeMore with Neomycin and Streptomycin

Reduce Acetylcholine release from Motor Endings Interfere with mobilization of synaptic vesicles By antagonizing calciumDecreased sensitivity of the muscle end plates to Ach.

Non significant in otherwise normal cases in routine

Dangerous in Myasthenia gravis Direct administration of Aminoglycosides into pleural and

peritoneal cavities If patient received curare like muscle relaxant during

surgical procedure

Partially antagonized by IV calciumPartially antagonized by IV calcium

Page 20: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

StreptomycinStreptomycinNarrow spectrum (Gram negative + M. tuberculosis)Uses

Tuberculosis (First drug to show antitubercular activity)

(PESRI-25,20,15,10,5 mg/kg)Acts against extracellular bacilli (due to poor penetration in the

cell)

Also active against Atypical Mycobacterium (M. kansasii and M. avium intracellulare.)

Resistance develops fast (Never use streptomycin alone as antitubercular)

SABEPlague – (Streptomycin {Tetracycline}Tularemia- (DOC {Tetracyclines alternate}Brucellosis

Page 21: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Tularemia (rabbit fever, deer fly fever, and Ohara's fever)is caused by the bacterium Francisella tularensis a gram-negative,  nonmotile coccobacillus.

Depending on the site of infection, tularemia has six characteristic clinical symptoms: ulceroglandular , glandular, oropharyngeal, pneumonic, oculoglandular, and typhoidal.

Brucellosis, also called Bang's disease, Crimean fever, Gibraltar fever, Malta fever, Mediterranean fever, rock fever, or undulant fever is a highly contagious zoonosis caused by ingestion of unsterilized milk or meat . Transmission from human to human, through sexual contact or from mother to child, is rare but possible.

Brucella are small, gram-negative, non-motile, non-spore-forming, rod shaped (coccobacilli) bacteria. They function as facultative intracellular parasites .

Plague is a deadly infectious disease that is caused by the enterobacteria Yersinia pestis. The symptoms of plague depend on the concentrated areas of infection in each person: such asbubonic plague in lymph nodes, septicemic plague in blood vessels, pneumonic plague in lungs, and so on. It is treatable if detected early.

Page 22: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Pyrazinamide (25)– Cidal, Intra, Inhibition of Mycolic Acid, Hyperuricemia, Hepatotoxicity

Ethambutol (20)– Static, Inhibits arabinosyl transferase and inhibit Mycolic acid incorporation, Hyperuricemia, Optic Neuritis

Streptomycin (15)- NONE

Rifampicin (10)- Red discoloration, Cidal, Both Extra and Intra, Inhibition of DNA dependent RNA polymerase, Inducer, Hepatitis

Isoniazid (5)- Peripheral neuropathy , Pyridoxine, Inhibition of Mycolic Acid of cell wall, Cidal to multiplying, Both Extra and Intra

ATTATT

Page 23: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Gentamicin (Gentamicin)Gentamicin (Gentamicin)Most commonly used Aminoglycosides (Jantamycin)

Obtained from Micromonospora purpureaBroader spectrum ( But not effective in T.B)Synergism with Beta lactamsActivity decreases in presence of pusUses -Usually in combination with Penicillin,

Cephalosporin or Fluoroquinolones, (BA, CA, FA with or without M)

SABEUsually

in peritoneal dialysate in topical creams for dressing and eye preparationscombined with Ticarcillin for Pseudomonas

Page 24: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Gentamicin-PMMA (Polymethyl methacrylate) A new drug delivery system for Osteomyelitis. Small acrylic beads impregnated with gentamicin. Threaded over surgical wire and implanted in bone cavity Left for 10days. Then removed along with wire.

Page 25: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

AmikacinAmikacinSemisynthetic derivative of

KanamycinNext to gentamicin regarding useResistant is lessWidest spectrum ( Second line

ATT)Reserve drug as alternate to

GentamicinMore hearing loss

Page 26: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

KanamycinKanamycinHighly OtotoxicHighly Nephrotoxic)Narrow spectrumRarely used now ( Second line anti-( Second line anti-

tubercular drug)tubercular drug)

Page 27: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

TobramycinTobramycinMore active against

Pseudomonas and ProteusReserve alternative of

Gentamicin

Page 28: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Sisomicin (Not Sisomycin)Sisomicin (Not Sisomycin)Obtained from Micromonospora

Same as gentamicinGreater efficacy against Pseudomonas

Page 29: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Netilmicin (Not Netilmicin (Not Netilmycin)Netilmycin)

Semisynthetic derivative of Sisomicin

Similar to Gentamicin but wider spectrum

Effective in Gentamicin resistant cases of Proteus, Pseudomonas, Klebsiella, E.coli

Page 30: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

ParomomycinParomomycinTo treat intestinal amoebiasisCryptosporidiosis in

immunocompromised (AIDS patients)

SpectinomycinSpectinomycinChlamydial treatment along with

Doxycycline

Page 31: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Framycetin (Soframycin)Framycetin (Soframycin)Too toxic for systemic use Topically as ointment, cream, eye

drops, etc.

Page 32: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

NeomycinNeomycinWide spectrumHighly Cochlear Toxic, and Nephrotoxic

Most common use is topical, ointment, eye and ear drops ◦( in combination with Polymyxin, Bacitracin as Nebasulf, Polybiotic cream, etc)

Neomycin with Polymyxin-B solution is used as an irrigant in urinary bladder to prevent bacteriuria associated with use of indwelling catheter.

Page 33: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Oral neomycin has damaging effect on intestinal villi- Malabsorption syndrome. Damages colonic flora- deficiency of vit. KSuperinfection

Not used systemically ( Except for preparation of

bowel for surgery and in Hepatic Coma or Hepatic Coma or Hepatic EncephalopathyHepatic Encephalopathy)

Page 34: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.
Page 35: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Hepatic coma (Hepatic Hepatic coma (Hepatic Encephalopathy)Encephalopathy)Colonic bacteria produce NH3.NH3 can cross BBBNH3 is toxic to nervous systemNH3 is converted to Urea by Liver (Urea does not cross

BBB) In hepatic failure conversion of NH3 to Urea does not occur Increased level of NH3 produces encephalopathy.Neomycin suppresses colonic floraNH3 production in colon is reducedNH3 level in blood is reduced

Other drug used for this purpose is LactuloseLactulose

Page 36: Aminoglycoside Antibiotics Prof. R. K. Dixit Pharmacology and Therapeutics K. G. M. U. Lucknow.

Recommended